Beam Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2019 | — | $-133.0M | $156.1M |
| Jun 2019 | — | $-151.9M | $37.9M |
| Sep 2019 | — | $-172.1M | $37.8M |
| Dec 2019 | — | $-201.1M | $37.2M |
| Mar 2020 | — | $261.4M | $126.1M |
| Jun 2020 | — | $230.8M | $125.3M |
| Sep 2020 | — | $200.1M | $137.9M |
| Dec 2020 | — | $245.6M | $162.2M |
| Mar 2021 | — | $422.4M | $97.2M |
| Jun 2021 | — | $548.6M | $212.0M |
| Sep 2021 | — | $853.8M | $612.0M |
| Dec 2021 | — | $826.7M | $560.0M |
| Mar 2022 | — | $829.1M | $296.8M |
| Jun 2022 | — | $800.2M | $265.6M |
| Sep 2022 | — | $714.5M | $156.5M |
| Dec 2022 | — | $733.5M | $232.8M |
| Mar 2023 | — | $761.5M | $249.8M |
| Jun 2023 | — | $811.6M | $225.5M |
| Sep 2023 | — | $778.9M | $169.0M |
| Dec 2023 | — | $981.3M | $435.9M |
| Mar 2024 | — | $913.5M | $287.8M |
| Jun 2024 | — | $854.1M | $292.8M |
| Sep 2024 | — | $791.3M | $230.2M |
| Dec 2024 | — | $733.5M | $282.0M |
| Mar 2025 | — | $1.13B | $527.9M |
| Jun 2025 | — | $1.05B | $282.1M |
| Sep 2025 | — | $966.0M | $268.0M |
| Dec 2025 | — | $1.24B | $294.9M |
| Mar 2026 | $100.2M | $1.16B | $288.3M |
| Jun 2026 | $100.3M | $1.07B | $219.8M |